ScholarIQanswers from OpenAlex
Teikyo University
InstitutionResearch output, impact & collaborations
Teikyo University is a institution indexed in ScholarIQ from OpenAlex.
What is known about Teikyo University?
ScholarIQrecord summary
Teikyo University is a research organisation in Tokyo, JP. OpenAlex records 27,295 works and 1,489,321 citations for it. 4,557 researchers list it as their most recent affiliation.
How many works does Teikyo University have?
ScholarIQindexed works
Teikyo University has 27,295 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Teikyo University have?
ScholarIQcitation count
Teikyo University has 1,489,321 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Teikyo University?
ScholarIQresearcher count
Teikyo University has 4,557 researchers in the ScholarIQ index.
What is the average h-index at Teikyo University?
ScholarIQavg h-index
Teikyo University has an average h-index of 39.4 in OpenAlex.
What is the ROR of Teikyo University?
ScholarIQror
The ROR for Teikyo University is on the source record.
What is the OpenAlex record for Teikyo University?
ScholarIQopenalex
The OpenAlex for Teikyo University is on the source record.
Who are the most-cited researchers behind Teikyo University?
ScholarIQtop researchers by citations
What are the most-cited papers on Teikyo University?
ScholarIQmost cited works
Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor
Fuyuki Ishikawa, Kohei Miyazono, Ulf Hellman, Hannes C. A. Drexler, Christer Wernstedt, Koichi Hagiwara, Kensuke Usuki, Fumimaro Takaku, Werner Risau, Carl‐Henrik Heldin
Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial
Kenjiro Kimura, Tatsuo Hosoya, Shunya Uchida, Masaaki Inaba, Hirofumi Makino, Shoichi Maruyama, Sadayoshi Ito, Tetsuya Yamamoto, Yasuhiko Tomino, Iwao Ohno, Yugo Shibagaki, Satoshi Iimuro, Naohiko Imai, Masanari Kuwabara, Hiroshi Hayakawa, Hiroshi Ohtsu, Yasuo Ohashi, Kenjiro Kimura, Tatsuo Hosoya, Sadayoshi Ito, Masaaki Inaba, Yasuhiko Tomino, Shunya Uchida, Hirofumi Makino, Seiichi Matsuo, Hisashi Yamanaka, Tetsuya Yamamoto, Iwao Ohno, Yugo Shibagaki, Satoshi Iimuro, Naohiko Imai, Masanari Kuwabara, Hiroshi Hayakawa, Tadao Akizawa, Tamio Teramoto, Hiroshi Kasanuki, Kenichi Yoshimura, Kenjiro Kimura, Tatsuo Hosoya, Yugo Shibagaki, Iwao Ohno, Hiroshi Sato, Shunya Uchida, Satoshi Horikoshi, Syoichi Maruyama, Masahiko Inaba, Yuji Moriwaki, Haruhito A. Uchida, Nagayuki Kaneshiro, Naohiko Imai, Hidekazu Moriya, Yasuhiro Komatsu, Shinya Kaname, K Hanaoka, Makoto Ogura, Masato Ikeda, Kenji Kasai, Akira Sugiura, Kazushi Takahashi, Kenichiro Kojima, Kosaku Nitta, Hirofumi Tamai, Hiroshi Nagaya, Senji Okuno, Ryusuke Kakiya, Hiroya Takeoka, Kyouji Hirata, Kenichiro Asano, Yasuo Fukaya, Yasushi Iwaida, Y Tsuneda, Shigeaki Nishimura, Takeyuki Hiramatsu, Yoshitaka Isaka, Takafumi Ito, Yukio Yuzawa, Kunihiro Yamagata, Tadashi Sofue, Yoshimi Jinguji, Keita Hirano, Kazuhiro Matsuyama, Teruhiko Mizumoto, Yuko Shibuya, Masahiro SUGAWARA, Moritoshi Kadomura, Yasuaki Teshima, Hiroshi Ohtani, Hiroki Kamata, Okawara Susumu, M. Fukushima, Katsumi Takemura, Eriko Kinugasa, Masami Kogure, Y. Ehara
Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
Peter Hillmen, Jeff Szer, Ilene C. Weitz, Alexander Röth, Britta Höchsmann, Jens Panse, Kensuke Usuki, Morag Griffin, Jean‐Jacques Kiladjian, Carlos de Castro, Hisakazu Nishimori, Lisa Tan, Mohamed Hamdani, Pascal Deschatelets, Cedric Francois, F Grossi, Temitayo Ajayi, Antonio M. Risitano, Régis Peffault de la Tour
Discontinuation of dasatinib in patients with chronic myeloid leukaemia who have maintained deep molecular response for longer than 1 year (DADI trial): a multicentre phase 2 trial
Jun Imagawa, Hideo Tanaka, Masaya Okada, Hirohisa Nakamae, Masayuki Hino, Kazunori Murai, Yoji Ishida, Takashi Kumagai, Seiichi Sato, Kazuteru Ohashi, Hisashi Sakamaki, Hisashi Wakita, Nobuhiko Uoshima, Yasunori Nakagawa, Yosuke Minami, Masahiro Ogasawara, Tomoharu Takeoka, Hiroshi Akasaka, Takahiko Utsumi, Naokuni Uike, Tsutomu Sato, Sachiko Ando, Kensuke Usuki, Satoshi Morita, Junichi Sakamoto, Shinya Kimura
The murine homolog of<i>SALL4</i>, a causative gene in Okihiro syndrome, is essential for embryonic stem cell proliferation, and cooperates with<i>Sall1</i>in anorectal, heart, brain and kidney development
Masayo Sakaki‐Yumoto, Chiyoko Kobayashi, Akira Sato, Sayoko Fujimura, Yuko Matsumoto, Minoru Takasato, Tatsuhiko Kodama, Hiroyuki Aburatani, Makoto Asashima, Nobuaki Yoshida, Ryuichi Nishinakamura
How much of the research on Teikyo University is open access?
ScholarIQopen access share
50%OPEN ACCESS